Skip to main content
. 2018 Dec 19;9(3):283–293. doi: 10.1016/j.jceh.2018.12.001

Figure 1.

Figure 1

The study treatment scheme is outlined for patients who completed treatment by HCV genotype. SOF, sofosbuvir; VEL, velpatasvir; RBV, ribavirin; GNT, genotype not tested; HCV, hepatitis C virus.